Comparative efficacy of octreotide and somatostatin in acute pancreatitis: a controlled trial of inflammatory markers and hospital length of stay.
Investigación Clínica · 01.06.2026 · 67 (2) · 189
DOI: 10.54817/ic.v67n2a03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigación Clínica, online erschienen am 01.06.2026. Verfasst von Qunchao Zhu und 5 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Acute pancreatitis is an acute pancreatic injury with multiple eti-ologies. Octreotide and somatostatin are commonly used treatments, but their clinical efficacy remains controversial. This study compares their effects on in-flammatory markers and hospital length of stay. One hundred and twenty pa-tients with acute pancreatitis admitted to The First People’s Hospital of Jiashan between January 2022 and December 2024 were retrospectively included and divided into two groups based on treatment modality, namely the control group (somatostatin treatment) and the experimental group (octreotide treatment), with 60 cases in each group. Serum amylase (AMY), serum lipase (LPS), C-reac-tive protein (CRP), interleukin-6 (IL -6), tumor necrosis factor-α (TNF-α), white blood cell count (WBC), serum albumin (ALB) content, procalcitonin (PCT), hos-pital stay duration, and the incidence of adverse reactions were assessed in both groups. Baseline data for the two groups were comparable, with no statistically significant differences (p>0.05). After seven days of medication, compared with the control group, patients in the experimental group had lower AMY, LPS, CRP, IL -6, TNF-α, WBC, and PCT (p
Zitieren
APA
Zhu, Q., Jiang, T., Li, Y., Jiang, S., Li, A., & Ma, C. (2026). Comparative efficacy of octreotide and somatostatin in acute pancreatitis: a controlled trial of inflammatory markers and hospital length of stay. Investigación Clínica, 67(2), 189. https://doi.org/10.54817/ic.v67n2a03
Vancouver
Zhu Q, Jiang T, Li Y, Jiang S, Li A, Ma C. Comparative efficacy of octreotide and somatostatin in acute pancreatitis: a controlled trial of inflammatory markers and hospital length of stay. Investigación Clínica. 2026;67(2):189. doi:10.54817/ic.v67n2a03
BibTeX
@article{Zhu2026,
author = {Zhu, Qunchao and Jiang, Tian and Li, Yan and Jiang, Sicong and Li, Aifang and Ma, Chendong},
title = {Comparative efficacy of octreotide and somatostatin in acute pancreatitis: a controlled trial of inflammatory markers and hospital length of stay},
journal = {Investigación Clínica},
year = {2026},
volume = {67},
number = {2},
pages = {189},
doi = {10.54817/ic.v67n2a03}
}
EUVIMED